Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
H-SQLLNAKYL-OH
3D-Ansicht

Biosynth logo

H-SQLLNAKYL-OH

Ref. 3D-PP47701

1mg
217,00 €
10mg
253,00 €
100mg
455,00 €
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 27. Dezember 2024

Produktinformation

Name:
H-SQLLNAKYL-OH
Beschreibung:

Peptide H-SQLLNAKYL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SQLLNAKYL-OH include the following: Highly focused TCR Vbeta repertoire is associated with a large number of naive precursors and robust CD8 T cell responses specific for a Plasmodium antigen (IRM14P V Braeckel-Budimir, J Harty - The Journal of Immunology, 2015 - journals.aai.orghttps://journals.aai.org/jimmunol/article/194/1_Supplement/198.10/55554 The Deubiquitinating Enzyme Cylindromatosis Dampens CD8+ T Cell Responses and Is a Critical Factor for Experimental Cerebral Malaria and Blood-Brain Barrier U Schmid, W Stenzel, J Koschel, M Raptaki - Frontiers in , 2017 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2017.00027/full Co-infection with Chikungunya virus alters trafficking of pathogenic CD8+ T cells into the brain and prevents Plasmodium-induced neuropathology TH Teo , SW Howland , C Claser , SY Gun - EMBO Molecular , 2018 - embopress.orghttps://www.embopress.org/doi/abs/10.15252/emmm.201707885 Investigating proteasome inhibitors as potential adjunct therapies for experimental cerebral malaria SW Howland , GXP Ng, SK Chia - Parasite Immunology, 2015 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/pim.12277 Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria SW Howland , CM Poh, SY Gun, C Claser - EMBO molecular , 2013 - embopress.orghttps://www.embopress.org/doi/abs/10.1002/emmm.201202273 Activated brain endothelial cells cross-present malaria antigen SW Howland , CM Poh, L Renia - PLoS pathogens, 2015 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1004963 Unravelling mysteries at the perivascular space: a new rationale for cerebral malaria pathogenesis SC Wassmer , TF de Koning-Ward , GER Grau - Trends in Parasitology, 2023 - cell.comhttps://www.cell.com/trends/parasitology/fulltext/S1471-4922(23)00285-4 CD8+ T Cells Induce Fatal Brainstem Pathology during Cerebral Malaria via Luminal Antigen-Specific Engagement of Brain Vasculature PA Swanson, GT Hart , MV Russo , D Nayak - PLoS , 2016 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1006022 A Plasmodium Cross-Stage Antigen Contributes to the Development of Experimental Cerebral Malaria P Fernandes , SW Howland , K Heiss - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2018.01875/full Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators KE Schmidt, JM Kuepper, B Schumak, J Alferink - PLoS , 2018 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0192717 Dendritic cell specific function of deubiquitinating enzyme OTUD7b in experimental cerebral malaria K Harit - 2024 - repo.bibliothek.uni-halle.dehttps://repo.bibliothek.uni-halle.de/handle/1981185920/117294 HVEM and CD160: regulators of immunopathology during malaria blood-stage F Muscate, N Stetter, C Schramm - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2018.02611/full Targeting glutamine metabolism rescues mice from late-stage cerebral malaria EB Gordon , GT Hart , TM Tran - Proceedings of the , 2015 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1516544112 Damage to the Blood-Brain Barrier during Experimental Cerebral Malaria Results from Synergistic Effects of CD8+ T Cells with Different Specificities CM Poh, SW Howland , GM Grotenbreg - Infection and , 2014 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.02180-14 Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection CL Edwards, SE Best, SY Gun, C Claser - European journal of , 2015 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201444824 Antigen presentation by discrete class I molecules on brain endothelium dynamically regulates T-cell mediated neuropathology in experimental cerebral malaria CE Fain , J Zheng, F Jin, K Ayasoufi , Y Wu , MT Lilley - bioRxiv, 2022 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2022.10.30.514412.abstract Inherently Reduced Expression of ASC Restricts Caspase-1 Processing in Hepatocytes and Promotes Plasmodium Infection C Marques-da-Silva , C Schmidt-Silva - The Journal of , 2024 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/doi/10.4049/jimmunol.2300440/266573 Brain endothelial cells exposure to malaria parasites links type I interferon signalling to antigen presentation, immunoproteasome activation, endothelium disruption AM Shafi, aca Vegvari , SW Howland - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1149107/full Suppression of Plasmodium MIF-CD74 signaling protects against severe malaria AB Garcia, E Siu , X Du, L Leng - : official publication of , 2021 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022605/

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP47701 H-SQLLNAKYL-OH

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.